DEXAMETHASONE SODIUM PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
When do Dexamethasone Sodium Phosphate patents expire, and what generic alternatives are available?
Dexamethasone Sodium Phosphate is a drug marketed by Amneal, Bel Mar, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Geneyork Pharms, Gland Pharma Ltd, Hikma, Intl Medication, Luitpold, Lyphomed, Micro Labs, Mylan Labs Ltd, Somerset, Somerset Theraps Llc, Teva Parenteral, Watson Labs, Wyeth Ayerst, Sola Barnes Hind, Bausch And Lomb, and Sandoz. and is included in forty NDAs.
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexamethasone Sodium Phosphate
A generic version of DEXAMETHASONE SODIUM PHOSPHATE was approved as dexamethasone sodium phosphate by HIKMA on September 7th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXAMETHASONE SODIUM PHOSPHATE?
- What are the global sales for DEXAMETHASONE SODIUM PHOSPHATE?
- What is Average Wholesale Price for DEXAMETHASONE SODIUM PHOSPHATE?
Summary for DEXAMETHASONE SODIUM PHOSPHATE
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 40 |
| Finished Product Suppliers / Packagers: | 18 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Clinical Trials: | 66 |
| Patent Applications: | 6,138 |
| DailyMed Link: | DEXAMETHASONE SODIUM PHOSPHATE at DailyMed |
Recent Clinical Trials for DEXAMETHASONE SODIUM PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Biotrial | Phase 3 |
| Quince Therapeutics S.p.A. | Phase 3 |
| Vietstar Biomedical Research | N/A |
Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DEXAMETHASONE SODIUM PHOSPHATE
US Patents and Regulatory Information for DEXAMETHASONE SODIUM PHOSPHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 040491-001 | Apr 11, 2003 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 087668-001 | Jul 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Parenteral | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 081125-001 | Aug 31, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 085606-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Parenteral | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 081126-001 | Aug 31, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
